About 5% of patients annually have no acceptable therapeutic option because of diffuse coronary disease without a discrete target for angioplasty, stenting or surgical bypass. Retrograde perfusion of the myoc
NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021